Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
The main functions of eosinophils include involvement in defence against parasites, allergic responses, tissue inflammation and immunity. Eosinophilia is a peripheral eosinophil count greater than the upper limit of normal range, usually around 0.45 x 109/L. In many cases the cause is clear - eg, atopic disease. However, the differential diagnosis includes many serious diseases, including malignancy.
- In the UK, eosinophilia is most often due to allergic conditions.
- Worldwide, helminth infections are the most common cause of eosinophilia.
- Travel history to assess whether a patient has travelled to an area that is endemic for certain infections, including helminthic infections.
- Medication and diet history to evaluate for allergic reactions associated with eosinophilia.
- History of symptoms associated with possible underlying causes (see 'Causes', below).
- A complete physical examination is required because diseases associated with eosinophilia can involve any part of the body.
- Allergy diseases: asthma, urticaria, eczema, allergic rhinitis, angioneurotic oedema.
- Drug hypersensitivity. Drugs which more commonly cause eosinophilia include anticonvulsants, allopurinol, sulfonamides and certain antibiotics. When eosinophilia is accompanied by a rash and systemic symptoms, this is called the DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms).
- Connective tissue diseases:
- Churg-Strauss syndrome. Vasculitis causing multisystem disease, but particularly of the lungs. It is associated with asthma, lung infiltrates and eosinophilia.
- Rheumatoid arthritis.
- Eosinophilic fasciitis. A rare condition characterised by eosinophilia with inflammation and thickening of the skin and fascia.
- Polyarteritis nodosa.
- Eosinophilia myalgia syndrome. A rare condition associated with myalgia and eosinophilia.
- Infections: in particular, parasitic infections including ascariasis, schistosomiasis, trichinellosis, visceral larva migrans, strongyloidiasis, echinococcosis, coccidioidomycosis.
- Hypereosinophilic syndromes (HES). A group of disorders causing high-grade persistent eosinophilia, where other causes have been excluded.
- Endocrine: adrenal insufficiency - eg, Addison's disease.
- Skin disease - pemphigus, dermatitis herpetiformis, erythema multiforme.
- Löffler's syndrome (accumulation of eosinophils in the lungs, due to parasitic infection).
- Löffler's endocarditis (restrictive cardiomyopathy with eosinophilia).
- Cholesterol emboli.
Investigation is guided by the history, examination, and clinical picture and may include:
- FBC, including differential white cell count.
- Renal function tests, LFTs.
- Urine tests: all patients with blood eosinophilia and haematuria and who have been in Africa should have their urine examined for the eggs of Schistosoma haematobium. Cystoscopy may be required to confirm the diagnosis.
- Lumbar puncture: CSF eosinophilia due to worm infections (eg, Angiostrongylus cantonensis), drug reactions, and coccidioidomycosis meningitis.
- CT scans of the lungs, abdomen, pelvis, and brain evaluate for focal defects due to diverse causes of eosinophilia - eg:
- Worm infections of the liver (eg, Fasciola hepatica) can cause focal hepatic lesions.
- Coccidioidomycosis can cause focal lesions in the lung, which are visible on CXR or CT scan.
- Hodgkin's lymphoma or non-Hodgkin's lymphoma can cause lymphadenopathy in the abdomen, which can be seen on a CT scan.
- Echocardiogram to assess for thrombi (eg, mural, endocardial) due to hypereosinophilic syndrome.
- Bone marrow biopsy may be required.
Further reading and references
Guideline for the investigation and management of eosinophilia; British Committee for Standards in Haematology (2016)
Montgomery ND, Dunphy CH, Mooberry M, et al; Diagnostic complexities of eosinophilia. Arch Pathol Lab Med. 2013 Feb137(2):259-69. doi: 10.5858/arpa.2011-0597-RA.
Rosenberg HF, Dyer KD, Foster PS; Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013 Jan13(1):9-22. doi: 10.1038/nri3341. Epub 2012 Nov 16.
Shomali W, Gotlib J; World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019 Oct94(10):1149-1167. doi: 10.1002/ajh.25617.
Tefferi A, Gotlib J, Pardanani A; Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc. 2010 Feb85(2):158-64. Epub 2010 Jan 6.
Mejia R, Nutman TB; Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012 Apr49(2):149-59. doi: 10.1053/j.seminhematol.2012.01.006.
Simon D, Simon HU; Eosinophilic disorders. J Allergy Clin Immunol. 2007 Jun119(6):1291-300
Pagnoux C, Guilpain P, Guillevin L; Churg-Strauss syndrome. Curr Opin Rheumatol. 2007 Jan19(1):25-32.
Eosinophilic fasciitis; DermNet NZ